Abstract
Purpose of Review
This review overviews the research base for obsessive-compulsive disorder (OCD) among three historically understudied populations; Latino/Latin Americans, Black/African Americans, and Sexual and Gender Minority individuals.
Recent Findings
Findings suggest that while core OCD symptoms are broadly similar across groups, sociocultural factors such as discrimination, minority stress, stigma, family context, spirituality, and access to care significantly influence symptom presentation, severity, and treatment utilization. Recent studies have evaluated assessment tools and provided evidence supporting exposure and response prevention, while emphasizing the importance of culturally responsive assessment and treatment. Large-scale initiatives are also improving representation in OCD research and addressing longstanding disparities in knowledge and care.
Summary
OCD presents similarly across diverse populations, but cultural and contextual factors shape symptom expression and treatment experiences. Future research should prioritize representative samples, culturally informed assessment, and greater access to evidence-based care.
Keywords: Obsessive-compulsive disorder, Latin American, African American, Sexual minority, Gender minority, Exposure and response prevention
Introduction
Obsessive-compulsive disorder (OCD) is a psychiatric disorder with a well-established core phenotype of frequent, intrusive, uncontrollable thoughts and repetitive behaviors. Although its impacts are considerable [1] and is experienced by individuals worldwide [2], effective psychotherapies exist, namely exposure and response prevention (ERP), which has a strong evidence base across numerous studies [1, 3]. Despite its severity, burden, and established treatments, OCD remains understudied and undertreated among minoritized populations [4–6]. Much of existing OCD research has been conducted primarily with heterosexual, cisgender White samples, potentially limiting generalizability of many findings.
Accordingly, this review provides an overview of the current literature on OCD among three historically understudied populations: Latino Americans, Black/African American individuals, and sexual and gender minority (SGM) individuals. Although many other historically marginalized populations also remain substantially understudied in OCD research, we focus on these three groups because each has developed a sufficient body of literature to support a focused review, in addition to the authors’ involvement in these works. The goal of this review is to synthesize the existing and emerging literature on OCD in these three populations, highlight clinically relevant considerations for assessment and treatment, and identify important directions for future research.
Latino Americans
Prevalence
One-year and lifetime prevalence of OCD among Latinos1 and within Latin American countries are between 1 and 3% [2, 7], though one meta-analysis of anxiety disorders in Latin America estimated OCD prevalence rates below 1%, with higher rates in urban compared to rural or mixed settings [8]. Despite these findings, Latinos remain significantly underrepresented in OCD research [4, 5, 9], however recent initiatives have sought to address this gap [10].
Clinical Presentation
As seen within the broader literature, symptom heterogeneity of OCD is also common among Latinos, with data from a large, predominately Brazilian sample providing evidence for eight broad symptom dimensions [11]. Symmetry symptoms may be especially common, with lifetime prevalence rates of 86% in a sample of over a thousand Brazilians with OCD; these symptoms were associated with earlier onset, depressive symptoms, and sensory phenomena [12]. Consistent with other populations examined, insight has also shown to be variable in Latino samples, with worse insight linked with more severe OCD [13]. Further, varied symptom dimensions appear to have varied comorbidity patterns [11, 14, 15]. In general major depressive disorder, social anxiety disorder, generalized anxiety disorder, and specific phobias have emerged as common comorbidities among Latino individuals with OCD [13–15].
Additional findings suggest variation in presentations across demographic groups. Latinos with OCD with a family history of the condition appear to demonstrate earlier onset, greater psychiatric comorbidity, and elevated sexual/religious and hoarding symptoms relative to those without a family history [16]. Gender differences have also been reported, with one study finding that men experienced greater sexual/religious symptoms, tic disorders, and alcohol use disorders, whereas women more commonly endorsed contamination/cleaning, aggressive, and hoarding symptoms alongside several body-focused-repetitive and eating-related comorbidities [14]. Cross country comparisons have also suggested both similarities and differences. For instance, Brazilian and U.S. samples generally demonstrated comparable symptom profiles in one investigation [17], although Brazilian individuals have reported higher rates of generalized anxiety disorder, post-traumatic stress disorder (PTSD), and tic disorders than those in non-Latin American countries [17, 18]. A smaller comparison between Costa Rican and U.S. adults found broadly similar symptom presentations despite somewhat greater severity and psychiatric comorbidity in the U.S. sample [19]. In an analogue study, young adults in Mexico endorsed higher obsessive-compulsive symptom scores across dimensions than U.S. participants, with spirituality appearing to function as a protective factor among Mexican individuals [20].
The link between higher OCD severity and greater impairment in quality of life (QoL) and functioning has also been replicated in samples of Latino adults and children [21, 22]. A study of Brazilians with OCD observed poorer QoL was linked with lower educational attainment, lower socioeconomic status, chronic illness course, and psychiatric comorbidity, with sexual/religious symptoms showing weaker associations in some analyses [22]. In a multinational Latino sample, OCD severity was found to be associated with reduced responsiveness to social interactions, while comorbid depressive symptoms were linked with diminished engagement in hobbies and goal-directed activities [23].
Suicidality also represents an important clinical concern within Latino OCD samples. Across Brazilian studies, approximately 10% of individuals with OCD reported either current suicidal ideation or prior suicide attempts, and over a third reporting lifetime active suicidal ideation [18, 24, 25]; these estimates appear similar to estimates meta-analytic estimates of suicidality in OCD as a whole [26]. Similar with non-Latino samples, greater comorbidity burden appears to be linked with higher suicidality [25], with comorbidities including mood disorders, PTSD, and substance use disorders associated with higher odds of past suicidality [24, 27, 28]. Further, suicidality is also greater among those with greater depression severity, lower quality of life and taboo symptoms, even when controlling for other factors [25, 29].
Several studies highlight broader contextual experiences among Latinos with OCD as well. Recent findings suggest that a meaningful proportion (e.g., greater than 25%) of both youth and adult samples reporting stigma- and discrimination-related concerns because of their OCD, with greater stigma associated with increased symptom severity and poorer functioning [21, 30]. Family accommodation also appears common and is associated with a broad range of more severe obsessive and compulsive symptoms among Brazilian individuals with OCD [31, 32]. Further, significant life events (e.g., emotional problems in the family, family financial problems) were reported by over 60% of individuals in one large Brazilian OCD sample and were associated with non-White racial identity, PTSD, sensory phenomena, and greater severity of sexual/religious and hoarding symptoms [33]. Relatedly, OCD-PTSD comorbidity was identified in 13.8% of a large multinational Latino sample and was associated with greater OCD symptom severity and poorer quality of life [34].
Considerations for Assessment and Psychological Treatment
Although commonly used OCD assessment measures have been translated into Spanish and Portuguese, only a handful have been validated for use specifically with Latinos. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was previously validated in Spanish for children and adults using smaller samples [35, 36], and one study supported general measurement invariance between Latino and White participants using the English-language Y-BOCS [37]. More recently, the Spanish Y-BOCS-II demonstrated strong validity and reliability in a multinational Latin American sample [38], with a follow-up study identifying a score of 22 as the cutoff for moderate OCD [39]. Spanish versions of the Obsessive Compulsive Inventory-4 and Florida Obsessive Compulsive Inventory-II have shown acceptable discriminative validity among Latinos with elevated obsessive-compulsive symptomatology [40]. The Dimensional Yale-Brown Obsessive-Compulsive Scale was developed in part using a Brazilian sample [41] and has demonstrated adequate psychometric properties in Brazilian populations [42]. Additionally, the Dimensional Obsessive-Compulsive Scale (DOCS) and the Obsessive-Compulsive Inventory–Child Version (OCI-CV) been validated among Mexican adults and Chilean youth, respectively [43, 44].
Treatment utilization among Latinos with OCD appears limited by systemic barriers and challenges in accurate symptom recognition. Barriers to care include language differences (within the U.S.), stigma, spiritual attributions of symptoms, concerns about treatment effectiveness, financial limitations, lack of availability, and preferences to manage symptoms independently [45, 46]. In a study of Latin American providers, overall rates of misidentification of varied OCD presentations ranged from 6.9 to 52.7% with presentations involving taboo thoughts more likely misdiagnosed [47]. Additionally, ERP was infrequently specifically recommended as a first line treatment (< 10% of the time), though accurate identification was associated with a greater likelihood of recommending first-line treatments [47]. Notably, these rates of misdiagnosis are largely consistent with what has been observed in U.S. clinician samples [48, 49].
In a large multinational sample of Latinos, 32.2% of individuals with OCD reported prior ERP [50], although recruitment through specialized clinics likely inflated these estimates. Indeed, while even in the U.S. there is a considerable lack of trained providers in ERP [49], this discrepancy is likely far greater in Central and South America [51, 52], though has yet to be formally estimated. Available data also suggest variability in psychiatric treatment access across the region, with serotonin reuptake inhibitor use for those being treated for OCD ranging from 40 to 88% across sampled Latin American sites [51]. However, more conservative estimates from the World Mental Health Survey found that only 7% of individuals with OCD in low- and middle-income countries – which include many Latin American nations – report receiving any form of treatment, in comparisons to rates of 40.5% in high income countries [2]. Within the U.S., Latinos with OCD may also be less likely to pursue higher levels of care (e.g., residential treatment); for instance, only 2.4% of 892 individuals receiving higher levels of care in one U.S. study identified as Latino [53], despite Latinos comprising 20% of the U.S. population [54]. Collectively, the existing literature suggests a considerable treatment gap for Latinos with OCD.
Treatment outcomes research among Latinos is limited relative to White, non-Latinos. Some studies suggest ethnicity is unrelated to treatment outcome in OCD [55], whereas others indicate that ethnicity and acculturation may moderate which interventions are most effective among Latino youth [56, 57]. Still, several studies conducted in Latin America, primarily in Brazil, support the effectiveness of cognitive-behavioral therapy/ERP for OCD across individual, group, and internet-delivered formats [58–61]. Consistent with findings in non-Latino populations, poorer insight, greater psychiatric comorbidity, and higher baseline symptom severity have been associated with worse treatment response in these samples [58, 62, 63].
Clinical guidance for ERP with Latino individuals emphasizes the need to distinguish culturally normative or faith-consistent behaviors from OCD symptoms and tailor exposures in ways that align with the individual’s cultural values, religious beliefs, and family context [7]. Effective ERP therefore may benefit from collaboration with family members or clergy, and requires attention to stigma and avoidance of exposures that could inadvertently undermine cultural identity, increase shame, or damage therapeutic rapport [7].
Future Directions
Until recently, OCD research among Latinos was generally concentrated in only a few countries (e.g., U.S., Mexico, Brazil). This gap is increasingly being addressed through the Latin American Trans-ancestry INitiative for OCD genomics [10], a multinational effort to expand Latino representation in OCD genetics research. With more than 5,000 Latin American participants with OCD, ongoing genotypic and phenotypic studies from this initiative are expected to substantially advance understanding of OCD in Latinos. Future research should also directly examine how factors such as acculturation, environmental context, immigration-related stressors, and specific spiritual and cultural beliefs shape OCD presentation, assessment, and treatment, given their broader role in Latino mental health [64]. Additionally, efforts are needed to expand dissemination of evidence-based treatments, including ERP, across Latino communities and Latin America broadly.
Black and African Americans
Prevalence
Approximately 1.6–2% of African Americans and Caribbean Black Americans2 meet criteria for OCD over the lifespan [65, 66]. However, current epidemiological knowledge remains limited by underrepresentation of Black individuals in OCD research [4, 5], raising concerns about accuracy estimating burden and clinical characteristics of OCD within Black populations.
Clinical Presentation
Some evidence suggests that, relative to non-Hispanic White individuals, African Americans may more frequently endorse contamination/washing symptoms, animal-related fears, and hoarding tendencies [67–71]. Within varied Black populations, one large study found few overall symptom differences across African American and Black Caribbean groups, aside from Haitian American participants, who reported fewer symptoms overall [72]. Research also suggests possible cultural variation in OCD-related cognitive processes, with African American individuals in one study more likely to engage in thought suppression and control strategies, whereas maladaptive interpretations of intrusive thoughts appeared more strongly linked to symptoms among European Americans [67]. Similarly, prior research found that African American participants scored higher than European Americans and Latinos in ratings of importance and need to control thoughts [70].
Emerging evidence highlights the role of racism, discrimination, and broader sociocultural stressors in shaping OCD symptoms among Black individuals. Greater racial discrimination has been associated with increased obsessive-compulsive symptom severity, including intrusive thoughts, contamination, harm, and taboo obsessions, as well as washing and repeating compulsions [72, 73]. Relatedly, elevated obsessive-compulsive symptoms among Black individuals in Canada – particularly foreign-born participants – has previously been linked with discrimination, internalized racism, and microaggressions, whereas social support appeared protective [74]. Discrimination may also prospectively predict greater obsessive-compulsive symptom distress, especially among Black individuals with a strong identification with an emphasis on Black racial identity [75]. Some scholars suggest that heightened contamination fears among Black individuals may reflect historical and ongoing impacts of racist stereotypes surrounding cleanliness and segregation [69]; consistent with this, one experimental study found that African American participants exposed to Jim Crow-related imagery demonstrated greater contamination-related avoidance [76]. Broader stressors may similarly exacerbate symptoms, as COVID-19 anxiety was associated with increased obsessive-compulsive symptoms among young Black adults partially through heightened psychological inflexibility [77]. Further, lower socioeconomic status may be associated with increased OCD risk and symptomatology among Black individuals [65, 66, 72].
The Sociocultural Model of OCD provides a useful framework for understanding that OCD symptoms among Black individuals are shaped not only by cognitive-behavioral processes, but also by broader sociocultural risk and protective factors, including income, racism and discrimination, stigma, parenting practices, access to treatment, social support, racial socialization, ethnic identity, and religious coping [78]. These contextual factors likely influence how symptoms are experienced, interpreted, reported, and treated. Research suggests that resilience factors, including social support, racial socialization, and ethnic identity may buffer psychopathology among Black individuals broadly [79, 80], though some culturally salient values, including religiosity and heightened moral responsibility, may also exacerbate OCD symptoms by amplifying distress associated with intrusive thoughts or contributing to symptom themes such as scrupulosity [66, 78, 81]. Further, one study of social networks among Black individuals found that frequent contact with friends and family was not protective against OCD, whereas more frequent negative family interactions were associated with increased risk [82], highlighting the need for further research on sociocultural contributors to OCD in Black individuals.
Black individuals with OCD may also differ in developmental course and comorbidity patterns, though this information largely comes from a limited body of research. African Americans may be more likely to exhibit adult-onset OCD rather than the late-adolescent onset more commonly reported in European American samples [65], potentially reflecting the influence of racism contributing to OCD development. Additionally, Black individuals with OCD also appear to experience high rates of psychiatric comorbidity, with the same study finding that over 9 out of 10 Black individuals with OCD endorsed at least one comorbid diagnosis, including depressive, anxiety, and trauma related disorders [65].
Considerations for Assessment and Psychological Treatment
Cross-cultural differences in OCD symptom presentation and interpretation among Black individuals have important implications for assessment, particularly because many standardized diagnostic instruments were developed and validated in predominantly White samples. Several self-report OCD measures, including the Padua Inventory [83] and the Maudsley Obsessional Compulsive Inventory [84] demonstrate inadequate psychometric properties for Black adults. Additionally, even when administered by well-trained clinicians, the Structured Clinical Interview for DSM-IV Axis I Disorders failed to correctly identify OCD in 33.8% of African American adults in one investigation [85]. Although some evidence supports the validity of the Y-BOCS and Obsessive-Compulsive Inventory-Revised (OCI-R) for African American populations [86, 87], one measurement invariance study found substantial non-invariance in the Y-BOCS Obsessions scale for Black individuals, suggesting caution when comparing scores with White individuals. Thus, further work is needed in developing measures that are valid for this population.
Black individuals with OCD face multiple barriers to timely, accurate, and effective care. Prominent barriers include cost, stigma and fear of judgment, concerns about therapeutic processes (e.g., being forced change, unsure where to find help or what to expect, feeling treatment will not work), time constraints, and beliefs that treatment may not be necessary [88]. Concerns about unfair treatment based on race or ethnicity and historical medical mistreatment of Black individuals may further discourage engagement [78, 88], highlighting how anticipated discrimination and mistrust of healthcare systems can shape treatment participation. Reflecting this, fewer Black individuals receive treatment for their OCD than their White counterparts [53, 65, 88]. In one large recent study, fewer than 15% of African Americans endorsing obsessions and fewer than 8% endorsing compulsions reported seeking treatment for these concerns [89]. Greater perceived impairment and poorer self-rated mental health increased the likelihood of help-seeking, whereas lower socioeconomic status and education were associated with reduced help-seeking [89].
Research on OCD treatment outcomes among Black populations remains limited. Evidence suggests that ERP yields comparable outcomes among Black and European/White Americans [55, 66, 90]. However, a lack of cultural and contextual responsivity may negatively affect treatment seeking, therapeutic alliance, and adherence [90, 91]. As such, treatment considerations should extend beyond standard ERP delivery to include culturally responsive engagement, case conceptualization, and intervention. Clinical guidance emphasizes understanding how racism, stigma, religious values, family expectations, and community context may shape symptom meaning, disclosure, and treatment participation [66, 78, 91]. Although core mechanisms of ERP need not change, clinicians should carefully consider how exposures are framed, whether treatment rationales feel culturally relevant, and whether OCD symptoms have been adequately distinguished from realistic concerns shaped by lived experience [91]. For instance, it is critical to differentiate between maladaptive avoidance (i.e., related to OC symptoms) and adaptive avoidance (i.e., avoidance of environments with a higher likelihood of exposure to violence, discrimination) [92].
Future Directions
Substantial gaps remain in understanding how OCD develops, presents, and is treated among Black individuals. Research examining developmental trajectories, etiological mechanisms, and youth presentations remains especially limited, constraining understanding of culturally relevant risk and resilience factors and opportunities for early intervention [78]. Emerging initiatives such as the Black EquaLity in OCD NeuroGenomics study [93] and the Black and Living with OCD project aim to address these disparities by increasing representation in OCD research and examining culturally relevant lived experiences, risk factors, and barriers to care among Black individuals. Continued investment in culturally informed and community-engaged research will be critical for improving assessment, treatment engagement, and equity in OCD treatment.
Sexual and Gender Minority Individuals
Prevalence
There has been increased empirical interest in OCD among sexual and gender minority (SGM) individuals in the last five years, where prior, virtually no research existed. Emerging studies are imperative given evidence showing increased risk for OCD among SGM individuals. Cisgender sexual minority (SM) men and women are 52–56% more likely to be diagnosed with OCD compared to their matched sex peers [94]. This discrepancy is magnified across gender identity, where OCD is nearly five times more prevalent among gender minority (GM) individuals compared to cisgender heterosexual individuals. Among undergraduates, 12-month rates of OCD diagnosis or treatment are 9% for SM and 8% for GM individuals, in stark contrast to rates of 1% and 1–2% for heterosexual and cisgender individuals, respectively [95, 96]. SGM individuals also represent 15% of OCD treatment-seeking samples [97, 98] despite accounting for only 8% of the general U.S. population [99]. Indeed, SM identification in OCD treatment samples has increased over five years, particularly for those with bisexual identities [100].
Clinical Presentation
Recent studies show elevated OCD severity among GM individuals compared to cisgender individuals [101, 102], yet no difference in OCD severity between SM and heterosexual individuals [97, 103]. There is some evidence that SM individuals, particularly bisexual individuals, report less emotion regulation capacity [98] and greater obsessive beliefs related to perfectionism/intolerance of uncertainty and responsibility to prevent harm/overestimation of threat compared to heterosexual peers [104]. Additionally, psychiatric comorbidity is potentially greater among SM individuals with OCD than heterosexual peers [102].
Findings regarding clinical presentation of obsessive-compulsive symptoms are inconsistent, with more differences found in non-clinical than clinical samples. In non-clinical samples, SM individuals report more severe unacceptable thoughts symptoms, less severe contamination symptoms [105], and greater endorsement of relationship-focused obsessive-compulsive symptoms, particularly relating to doubt about partners’ love, compared to heterosexual peers [106]. Non-clinical samples have also found greater perfectionism and negative affect traits among SM individuals, highlighting potential OCD risk factors [106].
In clinical samples, however, findings have not replicated. In a recent clinical sample, earlier symptom profiles did not replicate across sexual orientation groups; rather, individuals questioning their identity reported less severe symmetry symptoms, although the size of the subgroup (n = 17) limits conclusions [97]. A separate study found elevated contamination symptoms among GM versus cisgender males [102]. However, this study likewise included a small sample of GM individuals (n = 17), limiting conclusions, and has yet to be evaluated in subsequent samples. Collectively, findings suggest that differences in obsessive-compulsive symptom presentation may be less detectable within intensive treatment settings where there is less variability in symptom severity.
Presentation of OCD among SGM individuals may be amplified by minority stressors. Broadly within SGM literature, the minority stress model posits that individuals face distal (external) stressors including discrimination, identity-based violence, rejection, harassment, and non-affirmation of identity, which have a downstream effect on proximal (internal) stressors including internalized stigma, identity concealment, and rejection expectation [107, 108]. Recently, Pinciotti and Feinstein proposed a cognitive behavioral-minority stress model of OCD among SGM individuals that integrates minority stress processes into existing theoretical models of OCD [109]. The model posits that minority stressors contribute to cognitive patterns reflecting inflated responsibility to detect threat and prevent harm, the presence and content of intrusive thoughts, appraisals of intrusive thoughts as dangerous and personally meaningful, and to maladaptive behavioral and emotional responses that reinforce and ultimately maintain OCD symptoms. Preliminary research has supported these pathways [110], revealing unique OCD-related salience of rejection sensitivity and internalized stigma for SM and identity-based victimization for GM individuals. A subsequent study showing that living in a progressive city is associated with less severe OCD among SGM individuals offers further evidence for the impact of SGM-based stigma and discrimination on OCD [101].
Considerations for Assessment and Psychological Treatment
Limited research has evaluated the suitability of existing OCD measures for SGM populations. In one SGM sample, the DOCS, Y-BOCS-II-Self Report (SR), and Obsessive Beliefs Questionnaire (OBQ)-Short-Form demonstrated consistent response patterns with broader OCD samples and strong factor structures and loadings, internal consistency, and convergent validity [111]. However, in another study, while the DOCS and the OBQ-44 demonstrated measurement invariance, the Y-BOCS-SR did not demonstrate configural invariance between SGM and non-SGM patients [112]. Taken together, findings offer some support for the use of these measures in SGM populations, but caution may be needed in comparing scores using the YBOCS-SR. More work is needed to evaluate the suitability of pre-existing clinician administered measures for OCD in this population.
Studies show no differences in overall treatment outcomes across sexual orientation groups [97, 113], although there is some suggestion that rates of improvement may differ, with lesbian/gay patients demonstrating the slowest improvement across sexual orientation groups in quality of life and bisexual patients demonstrating more rapid improvement in OCD severity compared to heterosexual peers [103]. Only one study has evaluated treatment outcomes in a small sample of GM individuals, finding significantly longer lengths of treatment stay compared to cisgender patients and no significant improvement in contamination or just right symptoms [102].
Clinicians might consider incorporating assessment of minority stress when working with SGM individuals with OCD [114]. This information can not only inform a more holistic conceptualization of the patient’s presenting concerns and treatment-complicating factors, but identify where a justice-based approach to treatment may be needed [115]. Justice-based treatment considers the broader impact of treatment on patient, provider, and society at large, ensuring that individual treatment gains do not come at a cost to marginalized communities (e.g., conducting exposures that stereotype SM individuals to address sexual orientation obsessions). Among SGM individuals, justice-based ERP allows patient and provider to discuss more explicitly the learned stigma that may be contributing to symptoms and identify adaptive avoidance behaviors that may be “off limits” for exposure therapy (e.g., a transgender individual avoiding public restrooms due to fear of violence rather than contamination). Among individuals with identity-related OCD themes (e.g., obsessions about sexual orientation, gender identity, racism), justice-based ERP is strongly preferred over approaches to ERP that involve participation in overcorrection exposures that may unintentionally stigmatize or tokenize marginalized communities [116]. More detailed treatment recommendations for assessment and treatment of SGM youth with OCD have been previously published [114, 117].
Future Directions
Empirical understanding of OCD in SGM individuals is in its infancy and much remains unknown about how sexual and gender minority stress contributes to the development, exacerbation, and maintenance of OCD. Experimental and longitudinal studies are needed to better understand these proposed pathways. Treatment outcomes research is needed to evaluate the effectiveness of justice-based ERP, particularly among SGM individuals who may be drawn to its more overt values-based nature. Although the current research based is largely limited by small sample sizes and convenience sampling; several emerging initiatives to purposively sample SGM individuals with OCD, such as the Pride OCD study [110], will significantly improve SGM representation within the literature.
Conclusions
This manuscript provided an overview of OCD research among Latino, Black/African American, and SGM individuals (see Table 1 for summary). Overall, OCD exhibits similar core phenomenology and responsiveness to ERP, while also being meaningfully shaped by sociocultural context, minority stress, and systemic inequities. Although prevalence estimates among Latino and Black populations generally appear comparable to those observed in the broader population, emerging evidence suggests elevated OCD rates among SGM individuals, particularly GM individuals. Further, while the literature provides examples of theoretical conceptual models to consider for Black and SGM individuals with OCD, no models for Latinos have been proposed. Across populations, treatment recommendations generally emphasized that the core principles of ERP need not fundamentally change, but that culturally responsive implementation is critical. Common themes included the importance of distinguishing culturally normative, identity-related experiences, or adaptive avoidance from OCD symptoms, incorporating sociocultural and minority stress factors into case conceptualization, attending to family, religious, and community contexts, and ensuring that exposures are delivered in ways that avoid reinforcing stigma, invalidating lived experiences, or damaging therapeutic rapport.
Table 1.
Overview of OCD literature findings among latino, black, and sexual & gender minority individuals
| Prevalence | Clinical presentation | Assessment | Treatment | |
|---|---|---|---|---|
| Latino American |
1–3% lifetime |
-Phenotypic variability is common, with Latino cultures and sociodemographic factors (e.g., gender, country) influencing presentation -Symptom severity contributes to lower quality of life -Stigma and adverse life experiences are common -Suicidality risk is heightened |
-Validated measures have been developed in both Spanish and Portuguese and are recommended for clinical use. |
-Misdiagnosis, especially among “taboo” presentations may be common -Many Latinos & individuals in Latin America likely do not receive treatment due to cultural and systemic barriers -ERP is effective, with worse insight, symptom severity, and comorbidity linked with worse response |
| Black and African American | 1.6-2% lifetime |
-Contamination/washing, animal-related fears, and hoarding may be common -Racism and discrimination are contributory to OCD severity -Sociocultural Model of OCD help explain OCD among Black and African American individuals. |
-Yale-Brown Obsessive Compulsive Scale should be interpreted cautiously -Padua Inventories and Maudsley Obsessional Compulsive Inventory lack support -Obsessive-Compulsive Inventory- Revised has some support |
-Barriers to treatment are common, including structural and attitudinal -ERP is effective, though exposures should be designed with cultural sensitivity to minimize inadvertent risk |
| Sexual and Gender Minority (SGM) |
8–9% 12-month among university students. |
-Elevated symptom severity among gender minorities, but not sexual minorities -Research on specific symptom presentations is mixed, and inconclusive -Cognitive behavioral-minority stress model is a new model specific to OCD among SGM individuals |
-Validated measures may be useful, but should be interpreted with caution, clinical expertise, and sensitivity to SGM status |
-ERP is effective across SGM groups, but limited research suggests slower responses among gay/lesbian individuals -Justice-based ERP may be more preferrable |
Note. OCD Obsessive-Compulsive Disorder, ERP Exposure and Response Prevention
It is important to consider several caveats to this review. First, the authors recognize the considerable heterogeneity within each population discussed and do not intend for these findings to serve as broad generalizations. Relatedly, individuals hold multiple intersecting identities that may uniquely shape OCD experiences and outcomes. Indeed, one study of intensive residential treatment found that greater cumulative marginalization was associated with higher baseline OCD severity and obsessive beliefs, as well as lower quality of life at discharge [118]. It should also be noted that only three historically underrepresented populations were addressed here, despite many other groups – including Middle Eastern, Asian, and Native American individuals – remaining substantially understudied in the OCD literature. Despite these caveats, this review provides an informed overview of emerging and ongoing efforts to expand the OCD literature across historically underrepresented populations and underscores the importance of continued research aimed at reducing disparities and advancing equitable care.
Key References
-
Cervin M, Miguel EC, Güler AS, Ferrão YA, Erdoğdu AB, Lazaro L, et al. Towards a definitive symptom structure of obsessive−compulsive disorder: a factor and network analysis of 87 distinct symptoms in 1366 individuals. Psychol Med. 2022 Oct;52(14):3267–79.
- ○This paper presents a comprehensive analysis of symptom clustering in OCD among a mostly Latino sample.
-
Dromer E, Jacob G, Williams MT, Moshirian Farahi SMM, Darius W, Kogan CS, et al. Obsessive-compulsive symptoms and related risk and protective factors in Black individuals in Canada. Front Psychol. 2025 Mar 6;16.
- ○This reference presents recent data on the presence of obsessive-compulsive symptoms in Black individuals, and the role of discrimination, racism, and social support in predicting symptoms.
-
George JR, Taylor RJ, Rouleau TM, Turner ED, Williams MT. Seeking Care for Obsessive-Compulsive Symptoms Among African Americans: Findings from the National Survey of American Life. Behav Ther. 2025 Jan 1;56(1):1–15.
- ○This investigation provides recent data on treatment seeking among Black individuals in the USA
-
Pinciotti CM, Castillo AA, Avery JE, Storch EA, Feinstein BA. Identity-Related Stress and Obsessive-Compulsive Disorder in Sexual and Gender Minority Individuals: A Test of the Cognitive Behavioral-Minority Stress Model. Behav Ther. 2026 Mar 1;57(2):295–313.
- ○This reference provides an overview and testing of a theoretical model explaining how minority stress may influence presentation among SGM individuals.
-
Pinciotti CM, Upshaw BM, Spencer SD, Park JM, Franklin ME, Wadsworth LP, et al. Preferences for Justice-Based Exposure and Response Prevention Among Individuals With Identity-Related Obsessive-Compulsive Disorder. Behav Ther. 2025 Jul;56(4):753–67.
- ○This manuscript briefly overviews justice-based ERP principles and details findings suggesting preference for this approach compared to overcorrection exposures.
-
Stein DJ, Ruscio AM, Altwaijri Y, Chiu WT, Sampson NA, Aguilar-Gaxiola S, et al. Obsessive-compulsive disorder in the World Mental Health surveys. BMC Med. 2025 Jul 9;23(1):416.
- ○This paper presents data on OCD prevalence and treatment rates across many countries, including those in Latin America.
-
Storch EA, Cheng JSC, Higham M, Muñoz JS, Cruz VZ, Berrones D, et al. Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale – Second Edition. Psychiatry Res. 2025 Jun 1;348:116456.
- ○This reference overviews the recent validation of the Spanish YBOCS-II for use among Latinos.
Author contributions
R.M. led the conceptualization of the manuscript. R.M., O.O., C.P., wrote the original draft of the manuscript text. A.W. prepared Table 1. All authors reviewed and edited the manuscript.
Data Availability
No datasets were generated or analysed during the current study.
Declarations
Disclosures
Dr. McCarty has no disclosures to report. Dr. Onyeka reports receiving research support from the Texas Child Mental Health Care Consortium and the International OCD Foundation. Dr. Pinciotti reports receiving research support from the Texas Child Mental Health Care Consortium and fees to be a consultant and workshop presenter with The Knowledge Tree and OCD Training School. Dr. Wiese reports receiving research support from the Texas Child Mental Health Care Consortium. Dr. Storch reports receiving research funding to his institution from the International OCD Foundation, Wellcome Trust, and NIH. He receives direct funding from the International OCD Foundation as well as MHNTI for providing training on treating obsessive-compulsive disorder with psychotherapy. He was a consultant for Brainsway and Biohaven Pharmaceuticals in the past 36 months. He owns stock options less than $5000 in NView (for distribution of the Y-BOCS and CY-BOCS) and receives royalties from OCD Scales LLC (for distribution of the Y-BOCS and CY-BOCS). He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, Routledge, and Jessica Kingsley.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Human and Animal Rights
This article does not contain any studies with human or animal subjects performed by any of the authors.
Footnotes
The authors acknowledge that Hispanic and Latino populations encompass diverse groups with distinct histories, cultures, and experiences spanning Mexico, Central and South America, the Caribbean, and their global diasporas. Latino ancestry itself reflects varying degrees of Indigenous, African, and European heritage shaped by Spanish and Portuguese colonization, and individuals may identify with different terms – including Latino/a, Latinx, Latine, Hispanic, Chicano/a, or Tejano/a – depending on personal, cultural, or regional preference. Because no single label can fully capture this diversity, and to maintain consistency with prior literature, the term “Latino” will be used throughout this work to refer broadly to individuals of Latin American descent.
In this manuscript, the term “Black individuals” is used to refer broadly to persons of African descent, including but not limited to African Americans. This terminology is intended to be inclusive of the diversity within the Black diaspora, while acknowledging that cultural, historical, and lived experiences may vary across groups. When findings pertain specifically to African American samples, this is noted explicitly.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Grant JE. Obsessive–Compulsive Disorder. N Engl J Med. 2014;371(7):646–53. 10.1056/NEJMcp1402176. [DOI] [PubMed] [Google Scholar]
- 2.Stein DJ, Ruscio AM, Altwaijri Y, Chiu WT, Sampson NA, Aguilar-Gaxiola S, et al. Obsessive-compulsive disorder in the World Mental Health surveys. BMC Med. 2025;23(1):416. 10.1186/s12916-025-04209-5 . PubMed PMID: 40629326; PubMed Central PMCID: PMC12239380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wang Y, Miguel C, Ciharova M, Amarnath A, Lin J, Zhao R, et al. The effectiveness of psychological treatments for obsessive-compulsive disorders: a meta-analysis of randomized controlled trials published over last 30 years. Psychol Med. 2024;54(11):2838–51. 10.1017/S0033291724001375. [DOI] [PubMed] [Google Scholar]
- 4.Williams M, Powers M, Yun YG, Foa E. Minority participation in randomized controlled trials for obsessive–compulsive disorder. J Anxiety Disord. 2010;24(2):171–7. 10.1016/j.janxdis.2009.11.004 . PubMed PMID: 20143498; PubMed Central PMCID: PMC3431431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bellato A, Raduà J, Stocker A, Lockman MS, Lall A, Ravisankar V, et al. Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders: A Meta-Analysis. JAMA Psychiatry. 2025;82(7):663–70. 10.1001/jamapsychiatry.2025.0666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wynn JK, Reavis EA. Representation of sexual and gender minorities in psychiatric research. Psychiatry Res. 2022;307:114324. 10.1016/j.psychres.2021.114324 . PubMed PMID: 34894423. [DOI] [PubMed] [Google Scholar]
- 7.Morris OJ, Wiese AD, Pinciotti CM, Pacheco R, Mallen MCM, Schweissing EJ, et al. Obsessive-compulsive disorder among individuals of Hispanic and Latin American ancestry: Cultural considerations for assessment and psychotherapy. Bull Menninger Clin. 2024;88(2):148–70. 10.1521/bumc.2024.88.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Errazuriz A, Avello-Vega D, Passi-Solar A, Torres R, Bacigalupo F, Crossley NA, et al. Prevalence of anxiety disorders in Latin America: a systematic review and meta-analysis. Lancet Reg Health Am. 2025;45:101057. 10.1016/j.lana.2025.101057 . PubMed PMID: 40225404; PubMed Central PMCID: PMC11986631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wetterneck CT, Little TE, Rinehart KL, Cervantes ME, Hyde E, Williams M. Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials. J Obsessive-Compulsive Relat Disorders. 2012;1(2):85–97. 10.1016/j.jocrd.2011.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Crowley JJ, Cappi C, Ochoa-Panaifo ME, Frederick RM, Kook M, Wiese AD, et al. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study protocol. Am J Med Genet B Neuropsychiatr Genet. 2024;195(4):e32962. 10.1002/ajmg.b.32962 . PubMed PMID: 37946624; PubMed Central PMCID: PMC11076176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cervin M, Miguel EC, Güler AS, Ferrão YA, Erdoğdu AB, Lazaro L, et al. Towards a definitive symptom structure of obsessive–compulsive disorder: a factor and network analysis of 87 distinct symptoms in 1366 individuals. Psychol Med. 2022;52(14):3267–79. 10.1017/S0033291720005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Vellozo AP, Fontenelle LF, Torresan RC, Shavitt RG, Ferrão YA, Rosário MC, et al. Symmetry Dimension in Obsessive-Compulsive Disorder: Prevalence, Severity and Clinical Correlates. J Clin Med. 2021;10(2):274. 10.3390/jcm10020274 . PubMed PMID: 33451078; PubMed Central PMCID: PMC7828517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shavitt RG, de Mathis MA, Oki F, Ferrao YA, Fontenelle LF, Torres AR, et al. Phenomenology of OCD: lessons from a large multicenter study and implications for ICD-11. J Psychiatr Res. 2014;57:141–8. 10.1016/j.jpsychires.2014.06.010 . PubMed PMID: 25012187; PubMed Central PMCID: PMC7326117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Torresan RC, Ramos-Cerqueira ATA, Shavitt RG, do Rosário MC, de Mathis MA, Miguel EC, et al. Symptom dimensions, clinical course and comorbidity in men and women with obsessive-compulsive disorder. Psychiatry Res. 2013;209(2):186–95. 10.1016/j.psychres.2012.12.006 . PubMed PMID: 23298952. [DOI] [PubMed] [Google Scholar]
- 15.Torres AR, Fontenelle LF, Shavitt RG, Ferrão YA, do Rosário MC, Storch EA, et al. Comorbidity variation in patients with obsessive-compulsive disorder according to symptom dimensions: Results from a large multicentre clinical sample. J Affect Disord. 2016;190:508–16. 10.1016/j.jad.2015.10.051 . PubMed PMID: 26561941. [DOI] [PubMed] [Google Scholar]
- 16.Lima MO, Saraiva LC, Ramos VR, Oliveira MC, Costa DLC, Fernandez TV, et al. Clinical characteristics of probands with obsessive-compulsive disorder from simplex and multiplex families. Psychiatry Res. 2024;331:115627. 10.1016/j.psychres.2023.115627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Medeiros GC, Torres AR, Boisseau CL, Leppink EW, Eisen JL, Fontenelle LF, et al. A cross-cultural clinical comparison between subjects with obsessive-compulsive disorder from the United States and Brazil. Psychiatry Res. 2017;254:104–11. 10.1016/j.psychres.2017.04.024 . PubMed PMID: 28457988; PubMed Central PMCID: PMC5517316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Brakoulias V, Starcevic V, Belloch A, Brown C, Ferrao YA, Fontenelle LF, et al. Comorbidity, age of onset and suicidality in obsessive–compulsive disorder (OCD): An international collaboration. Compr Psychiatr. 2017;76:79–86. 10.1016/j.comppsych.2017.04.002. [DOI] [PubMed] [Google Scholar]
- 19.Chavira DA, Garrido H, Bagnarello M, Azzam A, Reus VI, Mathews CA. A comparative study of obsessive-compulsive disorder in Costa Rica and the United States. Depress Anxiety. 2008;25(7):609–19. 10.1002/da.20357 . PubMed PMID: 17823962. [DOI] [PubMed] [Google Scholar]
- 20.Berman NC, Gallegos-Guajardo J, Reuman L, Ramirez M, Valdez G, Abramowitz JS. Cross-cultural differences in obsessive-compulsive symptom dimensions across young adults in Mexico and USA. Mental Health Relig Cult. 2020;23(5):443–54. 10.1080/13674676.2020.1793309. [Google Scholar]
- 21.McCarty RJ, Jensen M, Cruz EPJS, Sagarnaga MN, Quiroz PC, Miño T, et al. Mental health stigma in Latin American youth with obsessive-compulsive disorder. Psychiatry Res. 2026;361:117113. 10.1016/j.psychres.2026.117113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Velloso P, Piccinato C, Ferrão Y, Perin EA, Cesar R, Fontenelle LF, et al. Clinical predictors of quality of life in a large sample of adult obsessive-compulsive disorder outpatients. Compr Psychiatry. 2018;86:82–90. 10.1016/j.comppsych.2018.07.007 . PubMed PMID: 30086510. [DOI] [PubMed] [Google Scholar]
- 23.Wagner KM, Cervin M, Cheng JSC, Arriaga J, Cruz VZ, Berrones D, et al. Transdiagnostic links of reward processing in obsessive-compulsive disorder and depression. J Affect Disord. 2025;391:119886. 10.1016/j.jad.2025.119886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Torres AR, Ramos-Cerqueira ATA, Ferrão YA, Fontenelle LF, do Rosário MC, Miguel EC. Suicidality in obsessive-compulsive disorder: prevalence and relation to symptom dimensions and comorbid conditions. J Clin Psychiatry. 2011;72(1):17–26. . 10.4088/JCP.09m05651blu [DOI] [PubMed] [Google Scholar]
- 25.Velloso P, Piccinato C, Ferrão Y, Perin EA, Cesar R, Fontenelle L, et al. The suicidality continuum in a large sample of obsessive–compulsive disorder (OCD) patients. Eur Psychiatry. 2016;38:1–7. 10.1016/j.eurpsy.2016.05.003. [DOI] [PubMed] [Google Scholar]
- 26.Pellegrini L, Maietti E, Rucci P, Casadei G, Maina G, Fineberg NA, et al. Suicide attempts and suicidal ideation in patients with obsessive-compulsive disorder: A systematic review and meta-analysis. J Affect Disord. 2020;276:1001–21. 10.1016/j.jad.2020.07.115. [DOI] [PubMed] [Google Scholar]
- 27.Domingues-Castro MS, Torresan RC, Shavitt RG, Fontenelle LF, Ferrão YA, Rosário MC, et al. Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: Prevalence and predictors. J Affect Disord. 2019;256:324–30. 10.1016/j.jad.2019.06.018. [DOI] [PubMed] [Google Scholar]
- 28.Gentil AF, de Mathis MA, Torresan RC, Diniz JB, Alvarenga P, do Rosário MC, et al. Alcohol use disorders in patients with obsessive–compulsive disorder: The importance of appropriate dual-diagnosis. Drug Alcohol Depend. 2009;100(1):173–7. 10.1016/j.drugalcdep.2008.09.010. [DOI] [PubMed] [Google Scholar]
- 29.Cervin M, do Rosário MC, Fontenelle LF, Ferrão YA, Batistuzzo MC, Torres AR, et al. Taboo obsessions and their association with suicidality in obsessive-compulsive disorder. J Psychiatr Res. 2022;154:117–22. 10.1016/j.jpsychires.2022.07.044 . PubMed PMID: 35933855. [DOI] [PubMed] [Google Scholar]
- 30.Ferrão Y, Chedid P, Bolzan P, Brandelli Costa A, Ferrão Y. Stigmatization of patients with obsessive-compulsive disorder: An exploratory survey. 9. 2025;9. 10.52338/jopr.2025.4455
- 31.Gomes JB, Van Noppen B, Pato M, Braga DT, Meyer E, Bortoncello CF, et al. Patient and family factors associated with family accommodation in obsessive–compulsive disorder. J Neuropsychiatry Clin Neurosci. 2014;68(8):621–30. 10.1111/pcn.12172. [DOI] [PubMed] [Google Scholar]
- 32.de Matos MB, Pires AJ, Trettim JP, Scholl CC, Tabeleão VP, Stigger RS, et al. Family perception of the symptoms of Obsessive-Compulsive Disorder patient and the family accommodation. Int J Soc Psychiatry. 2022;68(1):73–81. 10.1177/0020764020981107 [DOI] [PubMed] [Google Scholar]
- 33.Kracker Imthon A, Antônio Caldart C, do Rosário MC, Fontenelle LF, Constantino Miguel E, Arzeno Ferrão Y. Stressful Life Events and the Clinical Expression of Obsessive–Compulsive Disorder (OCD): An Exploratory Study. J Clin Med. 2020;9(10):3371. 10.3390/jcm9103371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pinciotti CM, Buckland EK, Tapia-Cuevas V, Romero MJ, Obando D, Longhurst M, et al. Clinical presentation of comorbid obsessive-compulsive disorder and posttraumatic stress disorder in Latin American individuals. J Obsessive-Compulsive Relat Disorders. 2026;49:101011. 10.1016/j.jocrd.2026.101011. [Google Scholar]
- 35.Nicolini H, Herrera K, Páez F, de Carmona MS, Orozco B, Lodeiro G, et al. Traducción al español y confiabilidad de la Escala Yale-Brown para el Trastorno Obsesivo-Compulsivo. Salud Mental. 1996;19(Supl 3):13–6. [Google Scholar]
- 36.Ulloa RE, de la Peña F, Higuera F, Palacios L, Nicolini H, Avila JM. [Validity and reliability of the Spanish version of Yale-Brown obsessive-compulsive rating scale for children and adolescents]. Actas Esp Psiquiatr. 2004;32(4):216–21. PubMed PMID: 15232750. [PubMed] [Google Scholar]
- 37.Garnaat SL, Norton PJ. Factor structure and measurement invariance of the Yale-Brown Obsessive Compulsive Scale across four racial/ethnic groups. J Anxiety Disord. 2010;24(7):723–8. 10.1016/j.janxdis.2010.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Storch EA, Cheng JSC, Higham M, Muñoz JS, Cruz VZ, Berrones D, et al. Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale – Second Edition. Psychiatry Res. 2025;348:116456. 10.1016/j.psychres.2025.116456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pinciotti CM, Avery J, Zhang C, Muñoz JS, Berrones D, Cruz VZ, et al. Benchmarking empirical severity for the Yale-Brown Obsessive Compulsive Scale-Second Edition. J Affect Disord. 2025;390:119719. 10.1016/j.jad.2025.119719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Storch EA, McCarty RJ, Zehavi M, Ahmad M, Cruz VZ, Berrones D, et al. Predictive validity of the Obsessive-Compulsive Inventory-4 and Florida Obsessive-Compulsive Inventory-II severity scale. J Psychiatr Res. 2026;194:349–60. 10.1016/j.jpsychires.2025.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, et al. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry. 2006;11(5):495–504. 10.1038/sj.mp.4001798 . PubMed PMID: 16432526. [DOI] [PubMed] [Google Scholar]
- 42.Batistuzzo MC, Fontenelle L, Ferrão YA, Rosário MC, Miguel EC, Fatori D. Factor structure of the Dimensional Yale-Brown Obsessive-Compulsive Scale in a large sample of adults with obsessive-compulsive disorder. Braz J Psychiatry. 2022;44:57–60. 10.1590/1516-4446-2021-2088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.de la Treviño- B, Berman N, Fisak B, Ruvalcaba-Romero N, Gallegos-Guajardo J. Validation of The Dimensional Obsessive-Compulsive Scale for Mexican population. J Obsessive-Compulsive Relat Disorders. 2019;21:13–7. 10.1016/j.jocrd.2018.11.006. [Google Scholar]
- 44.Martínez-González AE, Rodríguez-Jiménez T, Piqueras JA, Vera-Villarroel P, Godoy A. Psychometric Properties of the Obsessive-Compulsive Inventory-Child Version (OCI-CV) in Chilean Children and Adolescents. PLoS ONE. 2015;10(8):e0136842. 10.1371/journal.pone.0136842 . PubMed PMID: 26317404; PubMed Central PMCID: PMC4552748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Orozco R, Vigo D, Benjet C, Borges G, Aguilar-Gaxiola S, Andrade LH, et al. Barriers to treatment for mental disorders in six countries of the Americas: A regional report from the World Mental Health Surveys. J Affect Disord. 2022;303:273–85. .031 PubMed PMID: 35176342; PubMed Central PMCID: PMC11345908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Newberry JA, Gimenez MA, Gunturkun F, Villa E, Maldonado M, Gonzalez D, et al. Mental health care-seeking and barriers: a cross-sectional study of an urban Latinx community. BMC Public Health. 2024;24(1):3091. 10.1186/s12889-024-20533-6 . PubMed PMID: 39516848; PubMed Central PMCID: PMC11545330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Perez MI, Limon DL, Candelari AE, Cepeda SL, Ramirez AC, Guzick AG, et al. Obsessive-Compulsive Disorder Misdiagnosis among Mental Healthcare Providers in Latin America. J Obsessive Compuls Relat Disord. 2022;32:100693. 10.1016/j.jocrd.2021.100693 . PubMed PMID: 34840937; PubMed Central PMCID: PMC8612600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Glazier K, Swing M, McGinn LK. Half of Obsessive-Compulsive Disorder Cases Misdiagnosed: Vignette-Based Survey of Primary Care Physicians. J Clin Psychiatry. 2015;76(6):7995. 10.4088/JCP.14m09110. [DOI] [PubMed] [Google Scholar]
- 49.Weinberg L, Martin LA, Post KM, Ricketts EJ. Psychologists’ Diagnostic Accuracy and Treatment Recommendations for Obsessive-Compulsive Disorder. J Clin Psychol. 2025;81(5):324–33. 10.1002/jclp.23775. [DOI] [PubMed] [Google Scholar]
- 50.Mathai DS, Robinson JO, Wagner K, Neitzke-Spruill L, Berrones D, Anderberg JL, et al. Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study. Braz J Psychiatry. 2025 ;29. 10.47626/1516-4446-2025-4316 [DOI] [PubMed]
- 51.Brakoulias V, Starcevic V, Albert U, Arumugham SS, Bailey BE, Belloch A, et al. Treatments used for obsessive-compulsive disorder-An international perspective. Hum Psychopharmacol. 2019;34(1):e2686. 10.1002/hup.2686 . PubMed PMID: 30628745. [DOI] [PubMed] [Google Scholar]
- 52.Alarcón RD. Mental health and mental health care in Latin America. World Psychiatry. 2003;2(1):54–6. [PMC free article] [PubMed] [Google Scholar]
- 53.Williams MT, Sawyer B, Leonard RC, Ellsworth M, Simms J, Riemann BC. Minority participation in a major residential and intensive outpatient program for obsessive-compulsive disorder. J Obsessive-Compulsive Relat Disorders. 2015;5:67–75. 10.1016/j.jocrd.2015.02.004. [Google Scholar]
- 54.Piña G, Martinez G. Key facts about U.S. Latinos. Pew Research Center [Internet]. 2025 Oct 22 [cited 2026 Jul 17]. Available from: https://www.pewresearch.org/short-reads/2025/10/22/key-facts-about-us-latinos/
- 55.Cougle JR, Grubaugh AL. Do psychosocial treatment outcomes vary by race or ethnicity? A review of meta-analyses. Clin Psychol Rev. 2022;96:102192. 10.1016/j.cpr.2022.102192. [DOI] [PubMed] [Google Scholar]
- 56.Peris TS, Rozenman MS, Bai S, Perez J, Thamrin H, Piacentini J. Ethnicity moderates outcome in family focused treatment for pediatric obsessive compulsive disorder. J Anxiety Disord. 2020;73:102229. 10.1016/j.janxdis.2020.102229 . PubMed PMID: 32361032. [DOI] [PubMed] [Google Scholar]
- 57.Patriarca GC, Rey Y, Marin CE, Yeguez CE, Pettit JW, Silverman WK. Parent involvement enhances CBTs for anxiety disorders in Hispanic/Latino youth: Acculturation as a moderator. J Consult Clin Psychol. 2022;90(10):827–36. 10.1037/ccp0000770 . PubMed PMID: 36355650; PubMed Central PMCID: PMC9727821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Belotto-Silva C, Diniz JB, Malavazzi DM, Valério C, Fossaluza V, Borcato S, et al. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial. J Anxiety Disord. 2012;26(1):25–31. 10.1016/j.janxdis.2011.08.008. [DOI] [PubMed] [Google Scholar]
- 59.Borges CP, Meyer E, Ferrão YA, Souza FP, Sousa MB, Cordioli AV. Cognitive-Behavioral Group Therapy versus Sertraline for Obsessive-Compulsive Disorder: Five-Year Follow-Up. Psychother Psychosom. 2011;80(4):249–50. 10.1159/000322028. [DOI] [PubMed] [Google Scholar]
- 60.Cabedo E, Belloch A, Carrió C, Larsson C, Fernández-Alvarez H, García F. Group Versus Individual Cognitive Treatment for Obsessive-Compulsive Disorder: Changes in Severity at Post-Treatment and One-Year Follow-up. Behav Cogn Psychother. 2010;38(2):227–32. 10.1017/S135246580999066X. [DOI] [PubMed] [Google Scholar]
- 61.de Mathis MA, Flygare O, Costa DLC, Morais I, Rocha J, Borcato S, et al. Acceptability and Feasibility of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Brazil. Behav Ther. 2026;57(1):176–87. .001 PubMed PMID: 41620242. [DOI] [PubMed] [Google Scholar]
- 62.Gomes JB, Cordioli AV, Bortoncello CF, Braga DT, Gonçalves F, Heldt E. Impact of cognitive-behavioral group therapy for obsessive-compulsive disorder on family accommodation: A randomized clinical trial. Psychiatry Res. 2016;246:70–6. 10.1016/j.psychres.2016.09.019. [DOI] [PubMed] [Google Scholar]
- 63.Raffin AL, Fachel JMG, Ferrão YA, de Souza FP, Cordioli AV. Predictors of response to group cognitive-behavioral therapy in the treatment of obsessive-compulsive disorder. Eur Psychiatry. 2009;24(5):297–306. 10.1016/j.eurpsy.2008.12.001. [DOI] [PubMed] [Google Scholar]
- 64.Galvan T, Venta A, Moreno O, Gudiño OG, Mercado A. Cultural stress is toxic stress: An expanded cultural stress theory model for understanding mental health risk in Latinx immigrant youth. Cultur Divers Ethnic Minor Psychol. 2024;30(4):863–75. 10.1037/cdp0000680 . PubMed PMID: 38780599. [DOI] [PubMed] [Google Scholar]
- 65.Himle JA, Muroff JR, Taylor RJ, Baser RE, Abelson JM, Hanna GL, et al. Obsessive-compulsive disorder among African Americans and blacks of Caribbean descent: results from the national survey of American life. Depress Anxiety. 2008;25(12):993–1005. 10.1002/da.20434. [DOI] [PubMed] [Google Scholar]
- 66.Wilson A, Thayer K. Cross-cultural differences in the presentation and expression of OCD in Black individuals: A systematic review. J Obsessive-Compulsive Relat Disorders. 2020;27:100592. 10.1016/j.jocrd.2020.100592. [Google Scholar]
- 67.Nota JA, Blakey SM, George-Denn DA, Jacoby RJ, Schubert JR, Abramowitz JS, et al. The experience of OCD-related intrusive thoughts in African and European Americans: Testing the generalizability of cognitive models of obsessive compulsive disorder. J Obsessive-Compulsive Relat Disorders. 2014;3(2):115–23. 10.1016/j.jocrd.2014.03.003. [Google Scholar]
- 68.Williams MT, Elstein J, Buckner E, Abelson JM, Himle JA. Symptom dimensions in two samples of African Americans with obsessive–compulsive disorder. J Obsessive-Compulsive Relat Disorders. 2012;1(3):145–52. 10.1016/j.jocrd.2012.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Williams MT, Turkheimer E. Identification and explanation of racial differences on contamination measures. Behav Res Ther. 2007;45(12):3041–50. 10.1016/j.brat.2007.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Wheaton MG, Berman NC, Fabricant LE, Abramowitz JS. Differences in Obsessive–Compulsive Symptoms and Obsessive Beliefs: A Comparison between African Americans, Asian Americans, Latino Americans, and European Americans. Cogn Behav Ther. 2013;42(1):9–20. 10.1080/16506073.2012.701663 . PubMed PMID: 23134374. [DOI] [PubMed] [Google Scholar]
- 71.George JR, Pittenger C, Kelmendi B, Lohr JM, Adams TG. Disgust sensitivity mediates the effects of race on contamination aversion. J Obsessive Compuls Relat Disord. 2018;19:72–6. 10.1016/j.jocrd.2018.08.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Williams MT, Taylor RJ, George JR, Schlaudt VA, Ifatunji MA, Chatters LM. Correlates of obsessive-compulsive symptoms among Black Caribbean Americans. Int J Mental Health. 2021;50(1):53–77. 10.1080/00207411.2020.1826261 . PubMed PMID: 33840831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Williams MT, Taylor RJ, Mouzon DM, Oshin LA, Himle JA, Chatters LM. Discrimination and symptoms of obsessive–compulsive disorder among African Americans. Am J Orthopsychiatry. 2017;87(6):636–45. 10.1037/ort0000285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Dromer E, Jacob G, Williams MT, Moshirian Farahi SMM, Darius W, Kogan CS, et al. Obsessive-compulsive symptoms and related risk and protective factors in Black individuals in Canada. Front Psychol. 2025;16. 10.3389/fpsyg.2025.1422900. [DOI] [PMC free article] [PubMed]
- 75.Willis HA, Neblett EW. OC symptoms in African American young adults: The associations between racial discrimination, racial identity, and obsessive-compulsive symptoms. J Obsessive-Compulsive Relat Disorders. 2018;19:105–15. 10.1016/j.jocrd.2018.09.002. [Google Scholar]
- 76.Olatunji BO, Tomarken A, Zhao M. Effects of Exposure to Stereotype Cues on Contamination Aversion and Avoidance in African Americans. J Soc Clin Psychol. 2014;33(3):229–49. 10.1521/jscp.2014.33.3.229. [Google Scholar]
- 77.Willis HA, Williams M, Ayala Y. COVID-19 anxiety’s influence on obsessive compulsive symptoms among African American young adults. J Affect Disord. 2026;406:121596. 10.1016/j.jad.2026.121596. [DOI] [PubMed] [Google Scholar]
- 78.Williams MT, Jahn ME. Obsessive–compulsive disorder in African American children and adolescents: Risks, resiliency, and barriers to treatment. Am J Orthopsychiatry. 2017;87(3):291–303. 10.1037/ort0000188. [DOI] [PubMed] [Google Scholar]
- 79.Loyd AB, Humphries ML, Moore C, Owens CL, Smith AM, Williams N. Identifying Risk and Protective Factors in Research on Mental Health and Black American Adolescents: 1990 Through 2022. J Black Psychol. 2024;50(4):448–75. 10.1177/00957984241249360. [Google Scholar]
- 80.Neblett EW. Racial, Ethnic, and Cultural Resilience Factors in African American Youth Mental Health. Ann Rev Clin Psychol. 2023;19(19, 2023):361–79. 10.1146/annurev-clinpsy-072720-015146. [DOI] [PubMed] [Google Scholar]
- 81.Himle JA, Taylor RJ, Chatters LM. Religious involvement and obsessive compulsive disorder among African Americans and Black Caribbeans. J Anxiety Disord. 2012;26(4):502–10. 10.1016/j.janxdis.2012.02. .003 PubMed PMID: 22397898; PubMed Central PMCID: PMC11610501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Himle JA, Taylor RJ, Nguyen AW, Williams MT, Lincoln KD, Taylor HO, et al. Family and friendship networks and obsessive-compulsive disorder among African Americans and Black Caribbeans. Behav Therapist. 2017;40(3):99–105. [PMC free article] [PubMed] [Google Scholar]
- 83.Williams MT, Turkheimer E, Schmidt KM, Oltmanns TF. Ethnic Identification Biases Responses to the Padua Inventory for Obsessive-Compulsive Disorder. Assessment. 2005;12(2):174–85. 10.1177/1073191105275620. [DOI] [PubMed] [Google Scholar]
- 84.Thomas J, Turkheimer E, Oltmanns TF. Psychometric Analysis of Racial Differences on the Maudsley Obsessional Compulsive Inventory. Assessment. 2000;7(3):247–58. 10.1177/107319110000700305. [DOI] [PubMed] [Google Scholar]
- 85.Chasson GS, Williams MT, Davis DM, Combs JY. Missed diagnoses in African Americans with obsessive-compulsive disorder: the structured clinical interview for DSM-IV Axis I disorders (SCID-I). BMC Psychiatry. 2017;17(1):258. 10.1186/s12888-017-1422-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Williams M, Davis DM, Thibodeau MA, Bach N. Psychometric properties of the Obsessive-Compulsive Inventory Revised in African Americans with and without obsessive-compulsive disorder. J Obsessive-Compulsive Relat Disorders. 2013;2(4):399–405. 10.1016/j.jocrd.2013.07.003. [Google Scholar]
- 87.Williams MT, Wetterneck CT, Thibodeau MA, Duque G. Validation of the Yale-Brown Obsessive-Compulsive Severity Scale in African Americans with obsessive-compulsive disorder. Psychiatry Res. 2013;209(2):214–21. 10.1016/j.psychres.2013.04.007. [DOI] [PubMed] [Google Scholar]
- 88.Williams MT, Domanico J, Marques L, Leblanc NJ, Turkheimer E. Barriers to treatment among African Americans with obsessive-compulsive disorder. J Anxiety Disord. 2012;26(4):555–63. . Assessment and Treatment of Anxiety Disorders in Ethnic Minority Adults and Children. 10.1016/j.janxdis.2012.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.George JR, Taylor RJ, Rouleau TM, Turner ED, Williams MT. Seeking Care for Obsessive-Compulsive Symptoms Among African Americans: Findings From the National Survey of American Life. Behav Ther. 2025;56(1):1–15. 10.1016/j.beth.2024.08.002. [DOI] [PubMed] [Google Scholar]
- 90.Carter MM, Mitchell FE, Sbrocco T. Treating ethnic minority adults with anxiety disorders: Current status and future recommendations. J Anxiety Disord. 2012;26(4):488–501. . Assessment and Treatment of Anxiety Disorders in Ethnic Minority Adults and Children. 10.1016/j.janxdis.2012.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Williams MT, Rouleau TM, Torre JTL, Sharif N. Cultural competency in the treatment of obsessive-compulsive disorder: practitioner guidelines. Cogn Behav Therapist. 2020;13:e48. 10.1017/S1754470X20000501. [Google Scholar]
- 92.Flowers SN, Sanchez AL, Siddiqui A, Weiss M, Becker-Haimes EM. Clinician-Reported Person-Centered Culturally Responsive Practices for Youth with OCD and Anxiety. Child (Basel). 2025;12(8):1034. 10.3390/children12081034 . PubMed PMID: 40868486; PubMed Central PMCID: PMC12384509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Williams IJ, Marquez DY, Lopez-lengowski KE, Bommiasamy M, Onyeka O, Cynthia, Underwood SJ, et al. Black EquaLity in OCD NeuroGenomics (BELONG): Study Protocol. Am J Med Genet Part B: Neuropsychiatric Genet. 2026;201(3):194–204. 10.1002/ajmgb.70002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Lu JA, Soltani S, Austin SB, Rehkopf DH, Lunn MR, Langston ME. Mental Health Disparities by Sexual Orientation and Gender Identity in the All of Us Research Program. JAMA Netw Open. 2025;8(1):e2456264. 10.1001/jamanetworkopen.2024.56264 . PubMed PMID: 39878980; PubMed Central PMCID: PMC11780479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Oswalt SB, Lederer AM. Beyond Depression and Suicide: The Mental Health of Transgender College Students. Social Sci. 2017;6(1):20. 10.3390/socsci6010020. [Google Scholar]
- 96.Pelts MD, Albright DL. An Exploratory Study of Student Service Members/Veterans’ Mental Health Characteristics by Sexual Orientation. J Am Coll Health. 2015;63(7):508–12. 10.1080/07448481.2014.947992. [DOI] [PubMed] [Google Scholar]
- 97.Pinciotti CM, Feinstein BA, Williams MT. Symptom Profiles and Intensive Treatment Outcomes in Sexual Minority and Heterosexual Patients With OCD. Behav Ther. 2025;56(1):16–31. 10.1016/j.beth.2024.06.006. [DOI] [PubMed] [Google Scholar]
- 98.Bezahler A, Kuckertz JM, McKay D, Falkenstein MJ, Feinstein BA. Emotion regulation and OCD among sexual minority people: Identifying treatment targets. J Anxiety Disord. 2024;101:102807. 10.1016/j.janxdis.2023.102807 . PubMed PMID: 38101252. [DOI] [PubMed] [Google Scholar]
- 99.Jones JM. Gallup.com [Internet]. 2024 [cited 2026 Apr 2]. LGBTQ+ Identification in U.S. Now at 7.6%. Available from: https://news.gallup.com/poll/611864/lgbtq-identification.aspx
- 100.Bezahler A, Feinstein BA, Falkenstein MJ, Kuckertz JM. Emerging trends in sexual minority identification and clinical implications for treating OCD and related disorders. Behav Therapist. 2023;46(5):194–9. [Google Scholar]
- 101.Munro M, Smith NG. Increased Obsessive-Compulsive Disorder Symptomology in U.S. Sexual Minority Adults Who Identify as Trans and/or Live in Politically Conservative Towns. Sex Res Soc Policy. 2026 Mar;13. 10.1007/s13178-026-01323-8.
- 102.Pinciotti CM, Nuñez M, Riemann BC, Bailey BE. Clinical Presentation and Treatment Trajectory of Gender Minority Patients With Obsessive-Compulsive Disorder. J Cogn Psychother. 2022;36(1):42–59. 10.1891/JCPSY-D-20-00022 . PubMed PMID: 35121678. [DOI] [PubMed] [Google Scholar]
- 103.Bezahler A, Feinstein BA, Falkenstein MJ, Kuckertz JM. Clinical Presentations and Treatment Outcomes Between Bi+, Gay/Lesbian, and Heterosexual Adults with OCD. Am J Orthopsychiatry. 2026;96(1):107–18. 10.1037/ort0000837 . PubMed PMID: 39964418; PubMed Central PMCID: PMC12353010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Bezahler A, Falkenstein MJ, Kuckertz JM. What Do You Believe? Differentiating Obsessive Beliefs between Bi+, Gay/Lesbian and Heterosexual Adults with OCD. J Obsessive Compuls Relat Disord. 2024;42:100898. 10.1016/j.jocrd.2024.100898 . PubMed PMID: 40786838; PubMed Central PMCID: PMC12333631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Pinciotti CM, Orcutt HK. Obsessive-compulsive symptoms in sexual minorities. Psychol Sex Orientat Gend Divers. 2021;8(4):487–95. 10.1037/sgd0000437. [Google Scholar]
- 106.Angelo NL, Brullo G, Marsiglia A, Tirelli A, Piroddi E, Viti C, et al. Romantic relationship obsessive-compulsive doubts, perfectionism, and DSM-5 personality traits in LGB people: a comparison with heterosexual individuals. Front Psychol. 2024;15:1187179. 10.3389/fpsyg.2024.1187179 . PubMed PMID: 38449756; PubMed Central PMCID: PMC10916694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Hendricks ML, Testa RJ. A conceptual framework for clinical work with transgender and gender nonconforming clients: An adaptation of the Minority Stress Model. Prof Psychology: Res Pract. 2012;43(5):460–7. 10.1037/a0029597. [Google Scholar]
- 108.Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychol Bull. 2003;129(5):674–97. 10.1037/0033-2909.129.5.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Pinciotti CM, Feinstein BA. A cognitive behavioral-minority stress model of obsessive-compulsive disorder in sexual and gender minority individuals. Clin Psychol Sci Pract. 2025;32(3):292–302. 10.1037/cps0000279. [DOI] [PubMed] [Google Scholar]
- 110.Pinciotti CM, Castillo AA, Avery JE, Storch EA, Feinstein BA. Identity-Related Stress and Obsessive-Compulsive Disorder in Sexual and Gender Minority Individuals: A Test of the Cognitive Behavioral-Minority Stress Model. Behav Ther. 2026;57(2):295–313. 10.1016/j.beth.2025.08.007. [DOI] [PubMed] [Google Scholar]
- 111.Pinciotti CM, Castillo AA, Feinstein BA, Wadsworth LP, Abramowitz JS, Riemann BC, et al. Psychometric properties of common self-report measures for obsessive-compulsive disorder in sexual and gender minorities. J Obsessive-Compulsive Relat Disorders. 2024;43:100907. 10.1016/j.jocrd.2024.100907. [Google Scholar]
- 112.Pinciotti CM, Higham ML, Avery JE, Wiese AD, Spencer SD, Kuckertz JM, et al. Measurement invariance of obsessive-compulsive disorder self-report measures in sexual and gender minority individuals. Psychol Assess. Advanced online publication. 10.1037/pas0001490 [DOI] [PubMed]
- 113.Bezahler A, Kuckertz JM, Schreck M, Narine K, Dattolico D, Falkenstein MJ. Examination of outcomes among sexual minorities in treatment for obsessive-compulsive and related disorders. J Obsessive-Compulsive Relat Disorders. 2022;33:100724. 10.1016/j.jocrd.2022.100724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Pinciotti CM, Bezahler A, Feinstein BA. Assessment and Treatment Considerations for Sexual and Gender Minority Youth with OCD. In: Guzick AG, Storch EA, editors. A Clinician’s Guide to Childhood Obsessive-Compulsive and Related Disorders. London: Routledge; 2025. pp. 339–59. 10.4324/9781003517429-17
- 115.Pinciotti CM, Smith Z, Singh S, Wetterneck CT, Williams MT. Call to Action: Recommendations for Justice-Based Treatment of Obsessive-Compulsive Disorder With Sexual Orientation and Gender Themes. Behav Ther. 2022;53(2):153–69. 10.1016/j.beth.2021.11.001. [DOI] [PubMed] [Google Scholar]
- 116.Pinciotti CM, Upshaw BM, Spencer SD, Park JM, Franklin ME, Wadsworth LP, et al. Preferences for Justice-Based Exposure and Response Prevention Among Individuals With Identity-Related Obsessive-Compulsive Disorder. Behav Ther. 2025;56(4):753–67. 10.1016/j.beth.2024.12.001. [DOI] [PubMed] [Google Scholar]
- 117.Pinciotti CM, Cusack CE, Rodriguez-Seijas C, Lorenzo-Luaces L, van Dyk IS, Galupo MP. Potential Harm in the Psychological Treatment of Sexual and Gender Minority Youth. Res Child Adolesc Psychopathol. 2025;53(5):715–27. 10.1007/s10802-024-01268-9 . PubMed PMID: 39644408. [DOI] [PubMed] [Google Scholar]
- 118.Wadsworth LP, Potluri S, Schreck M, Hernandez-Vallant A. Measurement and impacts of intersectionality on obsessive-compulsive disorder symptoms across intensive treatment. Am J Orthopsychiatry. 2020;90(4):445–57. 10.1037/ort0000447 . PubMed PMID: 32134311. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No datasets were generated or analysed during the current study.
